 |
Top 6 Schizophrenia treatment startups
Oct 11, 2024 | By Jason Kwon | 27 |
These startups develop new schizophrenia treatment technologies, like virtual reality systems, mental health management apps, electromagnetic brain stimulation...
1
Country: USA | Funding: $946.4M
Click Therapeutics is looking to boost work on an online platform of “prescription digital therapeutics.” The company’s leading product is Clickotine, deisgned for smoking cessation, that works as a phone app designed to help people stop smoking using input from Magellan Health, a behavioral healthcare company.
Click Therapeutics is looking to boost work on an online platform of “prescription digital therapeutics.” The company’s leading product is Clickotine, deisgned for smoking cessation, that works as a phone app designed to help people stop smoking using input from Magellan Health, a behavioral healthcare company.
2
Country: USA | Funding: $409M
Pear Therapeutics develops digital therapies to address a broad range of severe conditions including addiction, schizophrenia, pain, post-traumatic stress disorder, anxiety, depression, and sleep. PEAR’s eFormulationTM platform combines pharmaceutical preparations with user-friendly, customizable, and scientifically validated software applications. PEAR’s patented approach provides better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payors. Pear Therapeutics filed for bankruptcy
Pear Therapeutics develops digital therapies to address a broad range of severe conditions including addiction, schizophrenia, pain, post-traumatic stress disorder, anxiety, depression, and sleep. PEAR’s eFormulationTM platform combines pharmaceutical preparations with user-friendly, customizable, and scientifically validated software applications. PEAR’s patented approach provides better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payors. Pear Therapeutics filed for bankruptcy
3
Country: USA | Funding: $284.6M
Lyndra Therapeutics is a developer of a novel therapeutic platform designed to sustain extended drug release in oral dosage form.
Lyndra Therapeutics is a developer of a novel therapeutic platform designed to sustain extended drug release in oral dosage form.
4
Country: USA | Funding: $7.9M
Karuna Pharmaceuticals engages in development of drugs for the treatment of schizophrenia.
Karuna Pharmaceuticals engages in development of drugs for the treatment of schizophrenia.
5
Country: Czech Republic | Funding: CZK35M
Mindpax is a digital technology company that helps people who suffer from bipolar affective disorder and schizophrenia
Mindpax is a digital technology company that helps people who suffer from bipolar affective disorder and schizophrenia
6
Country: Israel | Funding: $1M
Fride Pharma is developing novel drugs to become a new class of treatment for Schizophrenia and Tourette syndrome
Fride Pharma is developing novel drugs to become a new class of treatment for Schizophrenia and Tourette syndrome
